Medical Management of Cushing’s Syndrome: Current and Emerging Treatments
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Medical Management of Cushing’s Syndrome: Current and Emerging Treatments
Authors
Keywords
-
Journal
DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-17
DOI
10.1007/s40265-019-01128-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing's Syndrome: A Systematic Meta-Analysis
- (2019) Jeffrey Wagner et al. Frontiers in Endocrinology
- Hepatic safety of ketoconazole in Cushing’s syndrome: results of a Compassionate Use Programme in France
- (2018) Jacques Young et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing’s syndrome
- (2018) Daniel K. Langlois et al. BMC Endocrine Disorders
- Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
- (2018) André Lacroix et al. Lancet Diabetes & Endocrinology
- Pituitary-Directed Therapies for Cushing’s Disease
- (2018) Fabienne Langlois et al. Frontiers in Endocrinology
- New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A
- (2018) Mariana Fuertes et al. Frontiers in Endocrinology
- Should we avoid using ketoconazole in patients with severe Cushing's syndrome and increased levels of liver enzymes?
- (2018) Marine Ollivier et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A meta-analysis of the prevalence of cardiac valvulopathy in hyperprolactinemic patients treated with Cabergoline
- (2018) C E Stiles et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification of recurrent USP48 and BRAF mutations in Cushing’s disease
- (2018) Jianhua Chen et al. Nature Communications
- Mitotane (op’DDD) restores growth and puberty in nine children with Cushing’s disease
- (2018) Emmanuelle Motte et al. Endocrine Connections
- Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
- (2017) Hélène Lasolle et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist
- (2017) Hazel J. Hunt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Diagnosis and Differential Diagnosis of Cushing’s Syndrome
- (2017) D. Lynn Loriaux NEW ENGLAND JOURNAL OF MEDICINE
- Role of tyrosine kinase inhibitors in the treatment of pituitary tumours
- (2017) Anat Ben-Shlomo et al. Current Opinion in Endocrinology Diabetes and Obesity
- Regulation of Corticosteroidogenic Genes by MicroRNAs
- (2017) Stacy Robertson et al. International Journal of Endocrinology
- Secondary Intracranial Tumors Following Radiotherapy for Pituitary Adenomas: A Systematic Review
- (2017) Ryuya Yamanaka et al. Cancers
- Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Adrenocorticotropic Hormone Production and Tumorous Corticotroph Cell Growth in AtT20 Cells
- (2016) Qing-Fang Sun et al. CHINESE MEDICAL JOURNAL
- Therapeutic Strategies for the Treatment of Severe Cushing’s Syndrome
- (2016) Krystallenia I. Alexandraki et al. DRUGS
- E2F1-mediated human POMC expression in ectopic Cushing’s syndrome
- (2016) Takako Araki et al. ENDOCRINE-RELATED CANCER
- ALD1613, A Novel Long-Acting Monoclonal Antibody to Control ACTH-Driven Pharmacology
- (2016) Andrew L. Feldhaus et al. ENDOCRINOLOGY
- Cabergoline for Cushing’s disease: a large retrospective multicenter study
- (2016) A Ferriere et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- FKBP5 mRNA Expression Is a Biomarker for GR Antagonism
- (2016) Utsav Bali et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Testicular Receptor-4: Novel Regulator of Glucocorticoid Resistance
- (2016) Dongyun Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Updates on the role of adrenal steroidogenesis inhibitors in Cushing’s syndrome: a focus on novel therapies
- (2016) Maria Fleseriu et al. Pituitary
- How effective is temozolomide for treating pituitary tumours and when should it be used?
- (2016) Carmel Halevy et al. Pituitary
- The Role of Isotretinoin Therapy for Cushing’s Disease: Results of a Prospective Study
- (2016) Lucio Vilar et al. International Journal of Endocrinology
- Recurrent gain-of-function USP8 mutations in Cushing's disease
- (2015) Zeng-Yi Ma et al. CELL RESEARCH
- The Treatment of Cushing's Disease
- (2015) Rosario Pivonello et al. ENDOCRINE REVIEWS
- Cabergoline Use for Pituitary Tumors and Valvular Disorders
- (2015) Renata S. Auriemma et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease
- (2015) K. Hayashi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients
- (2015) P. Burman et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
- (2015) Daniel Bengtsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
- (2015) Lynnette K. Nieman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease
- (2015) Ning-Ai Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cerebrovascular Events, Secondary Intracranial Tumors, and Mortality After Radiotherapy for Nonfunctioning Pituitary Adenomas: A Subanalysis From the Dutch National Registry of Growth Hormone Treatment in Adults
- (2015) N. C. van Varsseveld et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas
- (2015) Marco Losa et al. JOURNAL OF NEURO-ONCOLOGY
- A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease
- (2015) Mathias Riebold et al. NATURE MEDICINE
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- (2015) David M. Hyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease
- (2015) Maria Fleseriu et al. Pituitary
- Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study
- (2014) Rosario Pivonello et al. CLINICAL ENDOCRINOLOGY
- Activation of the Dopamine Receptor Type-2 (DRD2) Promoter by 9-Cis Retinoic Acid in a Cellular Model of Cushing's Disease Mediates the Inhibition of Cell Proliferation and ACTH Secretion Without a Complete Corticotroph-to-Melanotroph Transdifferentiation
- (2014) Gianluca Occhi et al. ENDOCRINOLOGY
- Outcomes of Proton Therapy for Patients With Functional Pituitary Adenomas
- (2014) Daniel A. Wattson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Ketoconazole in Cushing's Disease: Is It Worth a Try?
- (2014) Frederic Castinetti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Nelson’s syndrome: Single centre experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy
- (2014) Peter J. Wilson et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Treatment of Cushing's disease: a mechanistic update
- (2014) Daniel Cuevas-Ramos et al. JOURNAL OF ENDOCRINOLOGY
- Somatostatin receptor ligands and resistance to treatment in pituitary adenomas
- (2014) Daniel Cuevas-Ramos et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- MicroRNAs as Biomarkers in Pituitary Tumors
- (2014) Antonio Di Ieva et al. NEUROSURGERY
- Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing’s disease: results from an open-ended, open-label extension trial
- (2014) Jochen Schopohl et al. Pituitary
- Dual Effects of Ketoconazole cis-Enantiomers on CYP3A4 in Human Hepatocytes and HepG2 Cells
- (2014) Aneta Novotná et al. PLoS One
- High variability in baseline urinary free cortisol values in patients with Cushing's disease
- (2013) S. Petersenn et al. CLINICAL ENDOCRINOLOGY
- Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
- (2013) Robert R. Henry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- LCI699, a Potent 11β-hydroxylase Inhibitor, Normalizes Urinary Cortisol in Patients With Cushing's Disease: Results From a Multicenter, Proof-of-Concept Study
- (2013) Xavier Bertagna et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cushing’s disease: A single centre’s experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy
- (2013) P.J. Wilson et al. JOURNAL OF CLINICAL NEUROSCIENCE
- New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
- (2013) Maria Fleseriu et al. JOURNAL OF NEURO-ONCOLOGY
- Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide
- (2013) Akira Matsuno et al. Medical Molecular Morphology
- High Response Rates and Prolonged Survival in Patients With Corticotroph Pituitary Tumors and Refractory Cushing Disease From Capecitabine and Temozolomide (CAPTEM)
- (2013) Brad E. Zacharia et al. NEUROSURGERY
- Encouraging efficacy of modern conformal fractionated radiotherapy in patients with uncured Cushing’s disease
- (2013) Sweta Budyal et al. Pituitary
- Combination therapy for Cushing’s disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?
- (2013) M. Barbot et al. Pituitary
- Managing hyperglycemia in patients with Cushing’s disease treated with pasireotide: medical expert recommendations
- (2013) Annamaria Colao et al. Pituitary
- Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease
- (2013) L. Du et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and Safety of Higher Dose Stereotactic Radiosurgery for Functional Pituitary Adenomas: A Preliminary Report
- (2013) Ryan A. Grant et al. World Neurosurgery
- A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome
- (2012) Elena Valassi et al. CLINICAL ENDOCRINOLOGY
- Legalon® SIL: The Antidote of Choice in Patients with Acute Hepatotoxicity from Amatoxin Poisoning
- (2012) Ulrich Mengs et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
- (2012) Camille Baudry et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- THERAPY IN ENDOCRINE DISEASE: Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review
- (2012) Veronica A Preda et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Potential Role for Retinoic Acid in Patients with Cushing's Disease
- (2012) Francesca Pecori Giraldi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fluconazole inhibits human adrenocortical steroidogenesis in vitro
- (2012) R van der Pas et al. JOURNAL OF ENDOCRINOLOGY
- Medical Management of Persistent and Recurrent Cushing Disease
- (2012) Maria Fleseriu NEUROSURGERY CLINICS OF NORTH AMERICA
- A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
- (2012) Annamaria Colao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rhabdomyolysis in a Prostate Cancer Patient Taking Ketoconazole and Simvastatin: Case Report and Review of the Literature
- (2011) Jack L Watkins et al. ANNALS OF PHARMACOTHERAPY
- Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension
- (2011) David A. Calhoun et al. CIRCULATION
- Mitotane has a strong and a durable inducing effect on CYP3A4 activity
- (2011) Nielka P van Erp et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Mitotane, Metyrapone, and Ketoconazole Combination Therapy as an Alternative to Rescue Adrenalectomy for Severe ACTH-Dependent Cushing's Syndrome
- (2011) Peter Kamenický et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
- (2011) Hidenori Fukuoka et al. JOURNAL OF CLINICAL INVESTIGATION
- Medical suppression of hypercortisolemia in Cushing’s syndrome with particular consideration of etomidate
- (2011) Jens Heyn et al. Pituitary
- Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature
- (2011) A. K. Annamalai et al. Pituitary
- Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor
- (2011) N.-A. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies
- (2010) Christophe Le Tourneau et al. EUROPEAN JOURNAL OF CANCER
- Cabergoline monotherapy in the long-term treatment of Cushing's disease
- (2010) Ariane Godbout et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Aldosterone Synthase Inhibition With LCI699
- (2010) Laurence Amar et al. HYPERTENSION
- Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
- (2010) Richard A. Feelders et al. NEW ENGLAND JOURNAL OF MEDICINE
- Temozolomide for corticotroph pituitary adenomas refractory to standard therapy
- (2010) Troy H. Dillard et al. Pituitary
- Differential Expression of Somatostatin and Dopamine Receptor Subtype Genes in Adrenocorticotropin (ACTH)-secreting Pituitary Tumors and Silent Corticotroph Adenomas
- (2009) Toru TATENO et al. ENDOCRINE JOURNAL
- Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement
- (2008) B. M. K. Biller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MicroRNAs Differentially Expressed in ACTH-Secreting Pituitary Tumors
- (2008) Fernando Colbari Amaral et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro
- (2008) C de Bruin et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started